These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38301600)

  • 1. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
    Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
    Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
    Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
    Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
    Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
    Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
    Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
    Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
    Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
    Shah A; Box A; Brenn T; Flaman A
    J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
    Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
    Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
    Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
    Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
    Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
    Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
    Luo J; Sanchez M; Lee E; Hertzler H; Luong N; Mazzola E; Finstein B; Tamen R; Brisbane G; Nguyen T; Paik PK; Chaft JE; Cheng ML; Khalil H; Piha-Paul SA; Sholl LM; Nishino M; Jänne PA; DuBois SG; Hanna GJ; Shapiro GI; French CA
    J Thorac Oncol; 2024 May; 19(5):829-838. PubMed ID: 38154515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
    Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
    Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent novel
    Diolaiti D; Dela Cruz FS; Gundem G; Bouvier N; Boulad M; Zhang Y; Chou AJ; Dunkel IJ; Sanghvi R; Shah M; Geiger H; Rahman S; Felice V; Wrzeszczynski KO; Darnell RB; Antonescu CR; French CA; Papaemmanuil E; Kung AL; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30552129
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
    Chen M; Chen X; Zhang Y; Wang W; Jiang L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
    Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
    Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity.
    Xu B; Chen JF; Sarungbam J; Tickoo S; Dickson BC; Reuter VE; Antonescu CR
    Genes Chromosomes Cancer; 2022 Sep; 61(9):542-550. PubMed ID: 35430756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
    Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
    Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
    Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
    Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
    Chau NG; Ma C; Danga K; Al-Sayegh H; Nardi V; Barrette R; Lathan CS; DuBois SG; Haddad RI; Shapiro GI; Sallan SE; Dhar A; Nelson JJ; French CA
    JNCI Cancer Spectr; 2020 Apr; 4(2):pkz094. PubMed ID: 32328562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
    Chen M; Li S; Jiang L
    Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
    Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA
    Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.